219 related articles for article (PubMed ID: 34283652)
21. MicroRNA-1258, regulated by c-Myb, inhibits growth and epithelial-to-mesenchymal transition phenotype via targeting SP1 in oral squamous cell carcinoma.
Zhang H; Jiang S; Guo L; Li X
J Cell Mol Med; 2019 Apr; 23(4):2813-2821. PubMed ID: 30734471
[TBL] [Abstract][Full Text] [Related]
22. Daxx and TCF4 interaction links to oral squamous cell carcinoma growth by promoting cell cycle progression via induction of cyclin D1 expression.
Lin GJ; Huang YS; Lin CK; Huang SH; Shih HM; Sytwu HK; Chen YW
Clin Oral Investig; 2016 Apr; 20(3):533-40. PubMed ID: 26205068
[TBL] [Abstract][Full Text] [Related]
23. Identification and validation of potential novel biomarkers for oral squamous cell carcinoma.
Zhang M; Chen X; Chen H; Zhou M; Liu Y; Hou Y; Nie M; Liu X
Bioengineered; 2021 Dec; 12(1):8845-8862. PubMed ID: 34606406
[TBL] [Abstract][Full Text] [Related]
24. DYRK1A is required for maintenance of cancer stemness, contributing to tumorigenic potential in oral/oropharyngeal squamous cell carcinoma.
Martin CE; Nguyen A; Kang MK; Kim RH; Park NH; Shin KH
Exp Cell Res; 2021 Aug; 405(1):112656. PubMed ID: 34033760
[TBL] [Abstract][Full Text] [Related]
25. RAN and YBX1 are required for cell proliferation and IL-4 expression and linked to poor prognosis in oral squamous cell carcinoma.
Che X; Liu M; Li D; Li Z; Guo J; Jia R
Exp Cell Res; 2021 Sep; 406(2):112767. PubMed ID: 34364882
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA‑495 targets Notch1 to prohibit cell proliferation and invasion in oral squamous cell carcinoma.
Lv L; Wang Q; Yang Y; Ji H
Mol Med Rep; 2019 Jan; 19(1):693-702. PubMed ID: 30387817
[TBL] [Abstract][Full Text] [Related]
27. IFITM3 knockdown reduces the expression of CCND1 and CDK4 and suppresses the growth of oral squamous cell carcinoma cells.
Gan CP; Sam KK; Yee PS; Zainal NS; Lee BKB; Abdul Rahman ZA; Patel V; Tan AC; Zain RB; Cheong SC
Cell Oncol (Dordr); 2019 Aug; 42(4):477-490. PubMed ID: 30949979
[TBL] [Abstract][Full Text] [Related]
28. NDRG1 deficiency is associated with regional metastasis in oral cancer by inducing epithelial-mesenchymal transition.
de Lima JM; Morand GB; Macedo CCS; Diesel L; Hier MP; Mlynarek A; Kowalski LP; Maschietto M; Alaoui-Jamali MA; da Silva SD
Carcinogenesis; 2020 Jul; 41(6):769-777. PubMed ID: 32112078
[TBL] [Abstract][Full Text] [Related]
29. Baicalein inhibits the growth of oral squamous cell carcinoma cells by downregulating the expression of transcription factor Sp1.
Gao Z; Zhang Y; Zhou H; Lv J
Int J Oncol; 2020 Jan; 56(1):273-282. PubMed ID: 31746368
[TBL] [Abstract][Full Text] [Related]
30. MiR-139-5p inhibits the tumorigenesis and progression of oral squamous carcinoma cells by targeting HOXA9.
Wang K; Jin J; Ma T; Zhai H
J Cell Mol Med; 2017 Dec; 21(12):3730-3740. PubMed ID: 28780773
[TBL] [Abstract][Full Text] [Related]
31. High expression of Rab31 confers a poor prognosis and enhances cell proliferation and invasion in oral squamous cell carcinoma.
Li X; Zhu F; Liu Z; Tang X; Han Y; Jiang J; Ma C; He Y
Oncol Rep; 2021 Mar; 45(3):1182-1192. PubMed ID: 33469675
[TBL] [Abstract][Full Text] [Related]
32. TEAD4-YAP interaction regulates tumoral growth by controlling cell-cycle arrest at the G1 phase.
Takeuchi S; Kasamatsu A; Yamatoji M; Nakashima D; Endo-Sakamoto Y; Koide N; Takahara T; Shimizu T; Iyoda M; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
Biochem Biophys Res Commun; 2017 Apr; 486(2):385-390. PubMed ID: 28315328
[TBL] [Abstract][Full Text] [Related]
33. FKBP11 promotes cell proliferation and tumorigenesis via p53-related pathways in oral squamous cell carcinoma.
Qiu L; Liu H; Wang S; Dai XH; Shang JW; Lian XL; Wang GH; Zhang J
Biochem Biophys Res Commun; 2021 Jun; 559():183-190. PubMed ID: 33945996
[TBL] [Abstract][Full Text] [Related]
34. ERK-mediated upregulation of matrix metalloproteinase-2 promotes the invasiveness in human oral squamous cell carcinoma (OSCC).
Pramanik KK; Mishra R
Exp Cell Res; 2022 Feb; 411(1):112984. PubMed ID: 34951997
[TBL] [Abstract][Full Text] [Related]
35. Screening and identification of autophagy-related biomarkers for oral squamous cell carcinoma (OSCC) via integrated bioinformatics analysis.
Huang GZ; Lu ZY; Rao Y; Gao H; Lv XZ
J Cell Mol Med; 2021 May; 25(9):4444-4454. PubMed ID: 33837652
[TBL] [Abstract][Full Text] [Related]
36. Downregulation of Jumonji-C domain-containing protein 5 inhibits proliferation by silibinin in the oral cancer PDTX model.
Yang CY; Tsao CH; Hsieh CC; Lin CK; Lin CS; Li YH; Chang WC; Cheng JC; Lin GJ; Sytwu HK; Wang YL; Chen YW
PLoS One; 2020; 15(7):e0236101. PubMed ID: 32678829
[TBL] [Abstract][Full Text] [Related]
37. CMTM3 inhibits cell growth and migration and predicts favorable survival in oral squamous cell carcinoma.
Zhang H; Zhang J; Nan X; Li X; Qu J; Hong Y; Sun L; Chen Y; Li T
Tumour Biol; 2015 Sep; 36(10):7849-58. PubMed ID: 25946973
[TBL] [Abstract][Full Text] [Related]
38. In vitro and in vivo antitumor effects of chloroquine on oral squamous cell carcinoma.
Jia L; Wang J; Wu T; Wu J; Ling J; Cheng B
Mol Med Rep; 2017 Nov; 16(5):5779-5786. PubMed ID: 28849182
[TBL] [Abstract][Full Text] [Related]
39. HOXA1 is overexpressed in oral squamous cell carcinomas and its expression is correlated with poor prognosis.
Bitu CC; Destro MF; Carrera M; da Silva SD; Graner E; Kowalski LP; Soares FA; Coletta RD
BMC Cancer; 2012 Apr; 12():146. PubMed ID: 22498108
[TBL] [Abstract][Full Text] [Related]
40. Contactin 1 (CNTN1) expression associates with regional lymph node metastasis and is a novel predictor of prognosis in patients with oral squamous cell carcinoma.
Wu HM; Cao W; Ye D; Ren GX; Wu YN; Guo W
Mol Med Rep; 2012 Aug; 6(2):265-70. PubMed ID: 22580838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
